Cargando…
Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.
Animals treated with a sufficiently high dose of busulphan die about 14 days later from bone marrow failure. A single, appropriately timed injection of cyclophosphamide can save these mice. The nature of this protection is shown to be the cyclophosphamide induced elaboration of a humoral factor whic...
Autores principales: | Millar, J. L., Hudspith, B. N., Blackett, N. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1975
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024837/ https://www.ncbi.nlm.nih.gov/pubmed/764844 |
Ejemplares similares
-
The Effect of Cysteine on the Immunosuppressive Activity of Busulphan, Cyclophosphamide and Nitrogen Mustard
por: Addison, I. E., et al.
Publicado: (1971) -
Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide.
por: Millar, J. L., et al.
Publicado: (1978) -
Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016) -
Busulphan in the Treatment of Chronic Granulocytic Leukaemia
por: Bridges, J. M., et al.
Publicado: (1961) -
Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase
por: Al-Hashmi, Sulaiman, et al.
Publicado: (2012)